$HUTCHMED(00013)$ a leader in innovative pharmaceuticals, continues to break new ground! The current stock price is HKD 24.75, up 1.7% from the cost price of HKD 24.338, resulting in a paper gain of HKD 3,708.52! The company’s oncology pipeline reports frequent positive clinical results, overseas licensing and collaborations steadily advance, and its internationalization strategy for innovative drugs has entered a fruitful stage, fully unlocking long-term growth potential!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
